Low-Carbohydrate and Plant-Based Dietary Effects on Vascular Health

Hypertension Clinical Trial

Official title:

Short-term Effects of a Low-carbohydrate Diet and a Whole-food, Plant-based Diet on Newer Markers of Vascular Health

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05414851
• Other study ID #: RSRB 0007277
• Status: Active, not recruiting
• Phase: N/A
• Start date: December 20, 2022
• Est. completion date: June 1, 2024

Study information

• Verified date: February 2024
• Source: University of Rochester
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is a randomized trial with a crossover design to investigate the short-term effects of two different dietary patterns on markers of vascular health. A low-carbohydrate diet and a whole-food, plant-based diet will be used. In addition to more traditional markers (cholesterol, blood pressure, inflammation), endothelial progenitor cells and trimethylamine N-oxide will be assessed.

Description:

This study is an investigation of the short-term effects of two different diets on both conventional as well as newer markers of vascular health among subjects over the age of 50 who have a cardiovascular risk factor. The low-carbohydrate diet will be consistent with low-carbohydrate diet maintenance plans, with "net" carbs kept under 50g per day. The whole-food, plant-based diet will exclude animal foods, oils, and solid fats. Meals will be provided, and subjects will consume each diet for 2 weeks, with a 4-6 week washout period between dietary phases. Subjects will be randomized 1:1 to start with either the plant-based diet or the low-carbohydrate diet. Its primary aim is to assess the short-term effect of a whole-food, plant-based diet and a low-carbohydrate diet on levels of endothelial progenitor cells and trimethylamine N-oxide among this population. Secondarily, we will assess more conventional measures of vascular risk, including cholesterol, weight, blood pressure, insulin resistance, and inflammatory marker, as well as fullness and changes in nutritional intake.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 45
• Est. completion date: June 1, 2024
• Est. primary completion date: June 1, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 50 Years and older

Eligibility

Inclusion Criteria:

• Age >50

• Diagnosis of any of the following cardiovascular risk factors: hypertension (Diagnosis present in chart or use of antihypertensive medications); hyperlipidemia/dyslipidemia (non-HDL cholesterol = 130 within the past year or current use of antihyperlipidemic medication); prediabetes (HbA1c = 5.7% and < 6.5% in the past year); diabetes (HbA1c = 6.5% in the past year); obesity (body mass index = 30).

• Willing and able to comply with the protocol for the duration of the study, including food provision, scheduled meetings and testing visits.

• Able to speak and read English fluently because counseling and education is only available in English.

Exclusion Criteria:

• Active malabsorption syndrome (celiac disease, history of gastric bypass within the past year, uncontrolled Crohn's disease, protein-losing enteropathy, etc…)

• Use of any of the following medications that require close monitoring and adjustment during major dietary change: insulin, sulfonylureas, or warfarin

• Chronic or acute kidney disease, with eGFR < 50 on two or more lab tests in the past 6 months

• Diagnosis of cirrhosis or liver failure

• Hyperkalemia (defined as potassium >5.4 on two or more lab tests in the past 6 months)

• Major surgery in the past 3 months

• Myocardial infarction in the past 6 months

• Current, active eating disorder as determined by chart review, investigator assessment, or subject history

• Food allergies or intolerances that would interfere with eating study food or require special accommodation as determined by subject history, investigator assessment, or chart review

• Consuming a current diet described by the subject as vegetarian, vegan, very low-carbohydrate, or ketogenic

• Illicit drug use (not including marijuana)

• High risk alcohol use, based on subject history (defined as greater than 7 drinks/week for women and greater than 14 drinks/week for men)

Related Conditions & MeSH terms

• Heart Disease, Ischemic
• Heart Diseases
• Hyperlipidemias
• Hypertension
• Myocardial Ischemia

Intervention

Other:
• Whole-Food, Plant-Based Diet and Low-Carbohydrate Diet
Participants will consume two weeks of each diet, with a 4-6 week washout period in between. Meals and snacks are provided for convenience to enhance adherence to each dietary pattern, but subjects can add or include their own home-prepared foods as long as they meet dietary guidelines. Each dietary intervention will include an education session via Zoom teleconference, and at least 2 individual contacts by phone to address questions and assess for adverse events.

Locations

Country	Name	City	State
United States	UR Medicine Nutrition in Medicine Research Center	Webster	New York

Sponsors (1)

Lead Sponsor	Collaborator
University of Rochester

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Endothelial Progenitor Cells		2 weeks
Primary	trimethylamine N-oxide		2 weeks
Primary	HDL function		2 weeks
Secondary	Cholesterol Panel	Total, LDL, HDL, non-HDL cholesterol, and triglycerides	2 weeks
Secondary	Blood Pressure		2 Weeks
Secondary	Resting Heart Rate		2 weeks
Secondary	Weight		2 weeks
Secondary	Insulin resistance	HOMA-IR	2 weeks
Secondary	Insulin		2 weeks
Secondary	Blood Glucose		2 weeks
Secondary	Inflammatory Markers	hsCRP, TNF-a, IL-6	2 weeks
Secondary	Satiety Assessment	Adapted SLIM (satiety labeled intensity magnitude)	2 weeks
Secondary	Food "liking"	5 food liking factor scales adapted from 5-Factor Satiety Questionnaires	2 weeks
Secondary	Change in nutritional intake	assessed by 3 day food records at baseline and in second week of dietary phase	2 weeks